I am writing a series of endocrinology short (10 slide) presentations on key things i think you need to know as medical students.
I will do another presentation on complications in more depth
I will put some audio with it soon
The ability to carry out a thorough and slick diabetic foot examination is something every medic needs to master. This video aims to give you an idea of what's required in the OSCE and you can then customise the examination to suit your own personal style.
Make sure to head over to http://geekymedics.com/2010/10/10/diabetic-foot-examination/ to see the written guide alongside the video.
Like us on Facebook http://www.facebook.com/geekymedics
Follow us on Twitter at http://www.twitter.com/geekymedics
You should always adhere to your medical schools / local hospital trusts guidelines when performing examinations or clinical procedures.
FREE flashcards to quiz these video drugs: http://helphippo.com/flash/flashcards.html.
For Juvenile/Type II diabetes (insulin resistance), there are oral medications to control blood sugar. Please SUBSCRIBE - more cool stuff coming as we get more Hippo Helpers!
See our pharmacolyg playlist at: http://www.youtube.com/playlist?list=PLIPkjUW-piR2Ww8tUxJnhuJ8z8X-yQSuB
Visit: http://helphippo.com for archived videos, organized by topic/school year.
http://www.handwrittentutorials.com - This tutorial takes a look at the production of thyroid hormones in the Thyroid Gland. This includes the transport of iodine and the production of thyroglobulin in the Thyroid Follicles. For more entirely FREE tutorials and accompanying PDFs visit http://www.handwrittentutorials.com
Despite major advances in understanding the immunopathology of type 1 diabetes, the promise of successful immune-based therapies has so far been unfulfilled. This two-paper Series from The Lancet Diabetes & Endocrinology covers the current challenges faced in the development of immune-based therapies for type 1 diabetes and approaches to overcome them in the future. In the first Series paper, Mark Atkinson and colleagues discuss the challenge of modulating β-cell autoimmunity in type 1 diabetes, highlighting how gaps in understanding of disease pathogenesis and issues with study design have hampered advances in translating initially promising preclinical approaches into clinical therapies, and recommending several approaches to advance progress in this area. In the second Series paper, Bart Roep and colleagues focus on antigen-specific immunotherapy approaches, highlighting recent research advances and the opportunities and challenges of translating research findings into clinical strategies that prevent progressive loss of β-cell function and survival in patients.